Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China State Council Assesses Healthcare Reform Implementation

This article was originally published in PharmAsia News

Executive Summary

The China State Council Office of Healthcare Reform recently held a meeting to discuss the establishment of the essential drug system and pilot reform for public hospitals, two crucial aspects of the reform. By year end, 30 percent of basic medical institutions will need to lay out their plans for implementing the essential drug system, including production, circulation, pricing, applications, and reimbursement. This will ensure lower prices of essential drugs as well as timely allocation of compensation for medical institutions. Public hospitals will need to explore separating management and administrative roles, as well as attracting private capital investment to develop a diversified medical system. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts